openPR Logo
Press release

Carglumic Acid Market Projected to Reach US$ 314.4 Million by 2033 with a CAGR of Over 7.5%

06-18-2024 04:05 PM CET | Science & Education

Press release from: FactMR

Carglumic Acid Market Projected to Reach US$ 314.4 Million

Fact.MR forecasts the global carglumic acid market to grow from US$ 152.5 million in 2023 to US$ 314.4 million in 2033. This represents a CAGR of over 7.5% from 2023 to 2033.

Carglumic acid, a synthetic structural analog of N-acetylglutamate (NAG), is primarily used to treat hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. This rare genetic disorder leads to an accumulation of ammonia in the blood, which can be life-threatening. The Carglumic acid market has been witnessing growth due to increasing awareness of rare genetic disorders, advancements in healthcare infrastructure, and supportive government policies.

Get Free Sample Copy of This Report-https://www.factmr.com/connectus/sample?flag=S&rep_id=7068

Market Dynamics

Drivers

Increasing Prevalence of Genetic Disorders: With the rise in genetic screening and diagnostic techniques, the identification of metabolic disorders like NAGS deficiency has increased. This has driven the demand for specific treatments such as carglumic acid.

Advancements in Biotechnology: Innovations in biotechnological research have improved the production and efficacy of carglumic acid, making treatments more accessible and effective.

Government Support and Funding: Many governments provide funding and support for research and development of treatments for rare diseases. This support has facilitated the growth of the carglumic acid market.

Restraints

High Cost of Treatment: The production of carglumic acid is complex and costly, which translates to high treatment costs. This can limit its accessibility, particularly in low-income regions.

Limited Awareness: Despite improvements, there is still limited awareness about NAGS deficiency and its treatment options, which can restrict market growth.

Market Segmentation

By Dosage Form

Tablets: Tablets are the most common form of carglumic acid available in the market. They are preferred due to their convenience and precise dosage.

Dispersible Tablets: These are designed to dissolve in water, making them easier to administer, especially for pediatric and elderly patients who may have difficulty swallowing tablets.

By Application

NAGS Deficiency: The primary application of carglumic acid is in the treatment of NAGS deficiency. It is used to lower ammonia levels in the blood, preventing the severe consequences of hyperammonemia.

Other Hyperammonemia Conditions: Carglumic acid is also being explored for use in other conditions that cause elevated ammonia levels, broadening its potential market.

By Region

North America: This region dominates the carglumic acid market due to advanced healthcare infrastructure, high awareness, and substantial government support for rare disease treatments.

Europe: Europe is another significant market, driven by strong healthcare systems and funding for rare disease research.

Asia-Pacific: The market in this region is growing due to increasing healthcare investments and rising awareness about genetic disorders.

Rest of the World: Other regions are gradually catching up as awareness and healthcare infrastructure improve.

Competitive Landscape

The carglumic acid market is moderately competitive, with key players focusing on research and development, strategic partnerships, and mergers and acquisitions to enhance their market presence. Some prominent players include:

Orphan Europe (Recordati Group): A leading player in the market, Orphan Europe, specializes in treatments for rare diseases and has a significant presence in the carglumic acid market.

Civentichem LLC: This company is involved in the production and distribution of carglumic acid, focusing on expanding its reach and improving product availability.

AN PharmaTech: A key manufacturer of active pharmaceutical ingredients (APIs), including carglumic acid, AN PharmaTech plays a crucial role in the supply chain.

Future Outlook

The carglumic acid market is expected to continue growing, driven by ongoing advancements in genetic research, increasing prevalence of metabolic disorders, and expanding healthcare infrastructure globally. Additionally, initiatives to raise awareness about rare genetic disorders and their treatment options will likely boost market growth.

Innovations and Research

Future developments in the carglumic acid market may include:

Improved formulations for enhanced efficacy and patient compliance.

Research into broader applications for carglumic acid in treating other hyperammonemia conditions.

Development of cost-effective production methods to make treatments more affordable.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=7068

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carglumic Acid Market Projected to Reach US$ 314.4 Million by 2033 with a CAGR of Over 7.5% here

News-ID: 3543437 • Views:

More Releases from FactMR

Medical Device Complaint Management Market to Reach US$ 10.52 Billion by 2032 with a 7% CAGR
Medical Device Complaint Management Market to Reach US$ 10.52 Billion by 2032 wi …
The medical device complaint management market is expected to garner a market value of US$ 5.35 Bn in 2022, anticipated to register a positive CAGR of 7% in the forecast period 2022-2032 and reach a value of US$ 10.52 Bn. The Medical Device Complaint Management Market is a crucial segment within the healthcare and medical device industries, ensuring compliance, quality, and patient safety. This market encompasses systems and processes used by
Electronic Grade Silicon Market to Reach US$ 6.8 Billion by 2032, Growing at a CAGR of 5.8%
Electronic Grade Silicon Market to Reach US$ 6.8 Billion by 2032, Growing at a C …
The global electronic grade silicon market is currently valued at US$ 3.8 billion and is predicted to expand at a CAGR of 5.8% to reach US$ 6.8 billion by the end of 2032. Market Overview The electronic grade silicon market plays a crucial role in the semiconductor industry, serving as the primary material for manufacturing integrated circuits and other electronic components. Silicon, in its purest form, is an essential element in the
Global Ocular Drug Delivery Technology Market Valued at US$ 17.74 Billion in FY 2022
Global Ocular Drug Delivery Technology Market Valued at US$ 17.74 Billion in FY …
The global ocular drug delivery technology market is likely to be valued at US$ 17.74 Billion in FY 2022, up from US$ 16.4 Billion in 2021. Market Overview The ocular drug delivery technology market is a dynamic and rapidly evolving sector within the broader pharmaceutical and healthcare industry. This market is driven by the increasing prevalence of ocular diseases and disorders such as glaucoma, macular degeneration, diabetic retinopathy, and dry eye syndrome,
Rail Grease Market to Reach US$ 461.71 Million by 2034, Growing at a CAGR of 2.3%
Rail Grease Market to Reach US$ 461.71 Million by 2034, Growing at a CAGR of 2.3 …
The global rail grease market size is estimated at US$ 367.8 million in 2024. Global demand for rail grease is forecasted to rise at a CAGR of 2.3% and reach a market value of US$ 461.71 million by the end of 2034. Rail Grease Market Overview The rail grease market, a critical component in the maintenance and efficient operation of rail systems, has experienced significant growth in recent years. Rail grease, essential

All 5 Releases


More Releases for Carglumic

Carglumic Acid Market to Witness Huge Growth by 2028
Carglumic Acid market research report assists different industries to understand customer behavior towards particular product or service launch. It carries out detailed research and provides important market data about consumers. It assists different industries to formulate different strategies for expansion of business and increase the product portfolio in the marketplace. It aims at offering valuable market data to make effective decision. All the significant data provided here covers prediction of
Carglumic Acid Market Witness Widespread Expansion by 2026
Transparency Market Research (TMR) has compiled a new comprehensive report on the global carglumic acid market for the forecast period 2017 to 2026. The report offers insightful forecasts on global carglumic acid market, and has examined the market in detail, providing key market dynamics inclusively. In addition to the provision of intelligence on latest trends, restraining factors, and fostering factors affecting the market expansion, the report includes analysis on data
Carglumic Acid Market Companies Overview 2017 - 2026
The demand within the global market for carglumic acid has been rising on account of advancements in the pharmaceutical industry, finds Transparency Market Research (TMR). Carglumic acid is used to manufacture several forms of therapeutic tablets, and this is a key standpoint from the perspective of market growth. The leading vendors in the global carglumic acid market have set on a spree to tie up with new selling points for
Carglumic Acid Market to Grow by 7.5% in 2026
Carglumic acid is an orphan drug that is used for treating patients suffering from hyperammonemia, a urea cycle disorder that is caused due to the lack of a certain enzyme in the liver. This also implies deficiency of N-acetylglutamate (NAG) synthase. Carglumic acid helps in detoxification and removal of ammonia from blood cells. Carglumic acid is on the verge of becoming an indispensable tool for managing life-threating metabolic disorders that affect
Carglumic Acid Market Estimated to Flourish by 2026
Carglumic acid is an orphan drug that is used for treating patients suffering from hyperammonemia, a urea cycle disorder that is caused due to the lack of a certain enzyme in the liver. This also implies deficiency of N-acetylglutamate (NAG) synthase. Carglumic acid helps in detoxification and removal of ammonia from blood cells. According to a study by Transparency Market Research (TMR), the global market for carglumic acid is likely to
New Research Offers Carglumic Acid Market Insights During 2017- 2026
A latest research report titled as “Carglumic Acid Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026” has been recently added to the vast portfolio of Market Research Hub (MRH) online research offerings. This report is a professional and in-depth analysis on the present state and future prospect for the global market. It provides valuable information to the industry insiders, potential entrants or investors. It